AASLD EXPO: Liver biopsy

Background: Liver biopsy is a foundational tool in hepatology, providing direct histologic assessment of hepatic parenchyma. Although noninvasive approaches have substantially reduced the need for biopsy in practice, it continues to play a critical role in diagnosis, staging, and therapeutic decision-making across a broad spectrum of liver disorders. Methods: This Expert Practice Opinion (EXPO) document was created by a writing group of subject matter experts appointed by the AASLD Practice Guidelines Committee. Writing group members performed a targeted literature review and created expert opinion statements that were unanimously agreed upon. Results: Histopathologic evaluation of the liver is utilized for 3 major indications: (1) to establish a diagnosis, (2) to stage the severity of inflammation and/or fibrosis, and (3) to enhance clinical management of liver disease. Liver biopsy can be performed using a percutaneous, transjugular, or endoscopic ultrasound approach. Percutaneous liver biopsy is used in most patients, though transjugular liver biopsy is often performed in those with ascites or coagulopathy and/or when hepatic venous pressure gradient measurement is desired. Endoscopic ultrasound–guided liver biopsy is particularly attractive when endoscopy to evaluate and treat varices or portal pressure gradient measurement is desired. The different biopsy techniques appear to have similar safety profiles and yield adequate tissue when performed by experts. Liver biopsy has limitations, including sampling variability, interobserver differences in interpretation, and procedural complications. Conclusions: Liver biopsy continues to play an essential role in contemporary hepatology practice. Recent advances include the introduction of endoscopic ultrasound liver biopsy. Evolving applications—including the potential for molecular profiling, use of digital pathology, and assessment of therapeutic response—underscore the continued relevance of tissue-based evaluation in precision hepatology.

Authors

Institutions

Publication Details

Journal
Hepatology
Published
2026-10-07
DOI
https://doi.org/10.1097/hep.0000000000001828
Primary Topic
Liver Disease Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

AASLD EXPO: Liver biopsy

Douglas G. Adler, Elizabeth C. Verna, Don C. Rockey, Matthew Robert Kappus et al.
Hepatology
Liver Disease Diagnosis and Treatment
article

AASLD EXPO: Liver biopsy

Douglas G. Adler, Elizabeth C. Verna, Don C. Rockey, Matthew Robert Kappus, Elizabeth B. Rand, Elliot B. Tapper
article en

Abstract

Background: Liver biopsy is a foundational tool in hepatology, providing direct histologic assessment of hepatic parenchyma. Although noninvasive approaches have substantially reduced the need for biopsy in practice, it continues to play a critical role in diagnosis, staging, and therapeutic decision-making across a broad spectrum of liver disorders. Methods: This Expert Practice Opinion (EXPO) document was created by a writing group of subject matter experts appointed by the AASLD Practice Guidelines Committee. Writing group members performed a targeted literature review and created expert opinion statements that were unanimously agreed upon. Results: Histopathologic evaluation of the liver is utilized for 3 major indications: (1) to establish a diagnosis, (2) to stage the severity of inflammation and/or fibrosis, and (3) to enhance clinical management of liver disease. Liver biopsy can be performed using a percutaneous, transjugular, or endoscopic ultrasound approach. Percutaneous liver biopsy is used in most patients, though transjugular liver biopsy is often performed in those with ascites or coagulopathy and/or when hepatic venous pressure gradient measurement is desired. Endoscopic ultrasound–guided liver biopsy is particularly attractive when endoscopy to evaluate and treat varices or portal pressure gradient measurement is desired. The different biopsy techniques appear to have similar safety profiles and yield adequate tissue when performed by experts. Liver biopsy has limitations, including sampling variability, interobserver differences in interpretation, and procedural complications. Conclusions: Liver biopsy continues to play an essential role in contemporary hepatology practice. Recent advances include the introduction of endoscopic ultrasound liver biopsy. Evolving applications—including the potential for molecular profiling, use of digital pathology, and assessment of therapeutic response—underscore the continued relevance of tissue-based evaluation in precision hepatology.

Hepatology
Children's Hospital of Philadelphia (US), Medical University of South Carolina (US), Duke University (US), University of Michigan (US), Porter Adventist Hospital (US), Michigan Medicine (US), Columbia University (US)
Openalex Percentile: Top 12%
Liver Disease Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.